Trials / Withdrawn
WithdrawnNCT00135655
A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema
A Randomized, Double-Masked, Parallel, Group, Multi-Center, Dose Ranging Pilot Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and tolerability of three dose strengths of the study drug in subjects with post cataract extraction macular edema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | denufosol tetrasodium (INS37217) Intravitreal Injection |
Timeline
- Start date
- 2005-08-01
- First posted
- 2005-08-26
- Last updated
- 2013-05-21
Source: ClinicalTrials.gov record NCT00135655. Inclusion in this directory is not an endorsement.